Skip to main content

Table 2 Pediatric rheumatologists in the survey who have used biologics for JDM in combination with other therapies. Note-PR’s could answer more than once

From: Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

Monotherapy of a biologic 6 PR’s
Biologic + methotrexate 11 PR
Biologic + methotrexate + corticosteroids 30 PR
Biologic + methotrexate + corticosteroids +1 immune-suppressive (MMF, AZA, or CSA) 24 PR
Biologic + methotrexate +IVIG 25 PR
Biologic + other therapies 9 PR
  1. mtx oral, subcutaneous, or IV methotrexate, CS oral or intravenous corticosteroids, AZA azathioprine, MMF mycophenolate, CSA cyclosporine A